News
Vista Pharmaceuticals reports standalone net loss of Rs 5.86 crore in the March 2026 quarter
29-May-2026 | 17:38
Reported sales nil
Net Loss of Vista Pharmaceuticals reported to Rs 5.86 crore in the quarter ended March 2026 as against net loss of Rs 1.50 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 3.23 crore during the previous quarter ended March 2025.
For the full year,net loss reported to Rs 12.06 crore in the year ended March 2026 as against net loss of Rs 4.65 crore during the previous year ended March 2025. Sales declined 46.38% to Rs 5.40 crore in the year ended March 2026 as against Rs 10.07 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 0 | 3.23 | -100 | 5.40 | 10.07 | -46 |
| OPM % | 0 | -28.48 | - | -270.74 | -40.02 | - |
| PBDT | -7.58 | -0.89 | -752 | -15.40 | -4.55 | -238 |
| PBT | -7.77 | -1.07 | -626 | -16.15 | -5.29 | -205 |
| NP | -5.86 | -1.50 | -291 | -12.06 | -4.65 | -159 |
Powered by Capital Market - Live News